Watson announced that the FDA has approved Vancomycin HCl capsules, the generic version of ViroPharma‘s Vancocin HCl capsules.

Vancocin is a glycopeptide antibiotic indicated for enterocolitis due to S. aureus (including MRSA) and antibiotic-associated pseudomembranous colitis due to C. difficile. It exerts its bactericidal effects by inhibiting bacterial cell wall synthesis and interfering with cell membrane permeability and RNA synthesis.

Vancomycin HCl capsules will be available from Watson in 125mg and 250mg dosage strengths.

For more information call (800) 272-5525 or visit www.watson.com.